Beranda › Kanker Prostat › Michigan › Ann Arbor
Uji klinis Kanker Prostat di Ann Arbor, MI
27 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Ann Arbor (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Menerima pesertaFase 3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi jauhnya
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Menerima pesertaFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
- dan 4 lainnya
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Menerima pesertaFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi jauhnya
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
- dan 4 lainnya
Precision-Based Genomics in Prostate Cancer
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Menerima pesertaFase 1/2
- Research Site, Ann Arbor
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Menerima pesertaFase 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Menerima pesertaFase 3
- University of Michigan ( Site 0005), Ann Arbor
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Chelsea Hospital, Chelsea · 15 mi jauhnya
- dan 2 lainnya
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Menerima pesertaStudi observasional
- Rogel Cancer Center, Ann Arbor
EDRN Prostate MRI Biomarker Study
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Menerima pesertaFase 2
- University of Michigan Health, Ann Arbor
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
Menerima pesertaStudi observasional
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Menerima pesertaFase 3
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi jauhnya
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Menerima pesertaFase 2
- VA Ann Arbor Healthcare System, Ann Arbor
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
Menerima pesertaStudi observasional
- University of Michigan Rogel Cancer Center, Ann Arbor
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Menerima pesertaFase 1/2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Menerima pesertaFase 2/3
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Menerima pesertaFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
- dan 4 lainnya
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Menerima peserta
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
Menerima pesertaFase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Menerima pesertaFase 2Sukarelawan sehat diterima
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Menerima pesertaStudi observasional
- University of Michigan Rogel Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Ann Arbor
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Saint Joseph Mercy Chelsea, Chelsea · 15 mi jauhnya
- dan 1 lainnya
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN42 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Ann Arbor
- Kanker Payudara26 studi
- Kanker Paru Non-Sel Kecil26 studi
- Kanker (semua jenis)25 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Gagal Jantung22 studi
- Leukemia Mieloid Akut17 studi
- Penyakit Kardiovaskular16 studi
- Kanker Pankreas14 studi
- Melanoma12 studi
- Kanker Ginjal (Karsinoma Sel Renal)12 studi
- Karsinoma Sel Skuamosa Kepala dan Leher12 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.